Is Lincoln Pharmaceuticals stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Lincoln Pharmaceuticals pays dividends. Last time was Wednesday 30th of October 2024 where the investors holding the stock on Friday 13th of September 2024 were paid INR1.8 per share. Over the last 9 times between 2016 and 2024, Lincoln Pharmaceuticals has paid INR13 with an average of INR1.44 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Lincoln Pharmaceuticals 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR140.95, you would have made a profit of INR631.85 per share or 448.28%
Yes, the average daily trading liquidity for Lincoln Pharmaceuticals is INR91 867 thousand. You should therefore be able to get in and out of your positions relatively fast.
Lincoln Pharmaceuticals has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 14.88, the company's ability to pay off the debt is good. Lincoln Pharmaceuticals has a good net profit margin of 16.07% and should have high tolerances against inflation.
We have calculated the inflation risk for Lincoln Pharmaceuticals to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.